Amna Ali
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Zeeshan Ahmad (8 shared papers)Ming‐Wei Chang (6 shared papers)Muhammad Sohail Arshad (7 shared papers)Elshaimaa Sayed (3 shared papers)Omar Qutachi (3 shared papers)Alsiddig Osama (1 shared paper)Neenu Singh (3 shared papers)J. Gordon Hall (1 shared paper)
- Journals
- Journal of Drug Delivery Science and Technology (2 papers)International Journal of Pharmaceutics (2 papers)Scientific Reports (1 paper)Canadian Journal of Diabetes (1 paper)Pharmaceutics (1 paper)
- Partner nations
- PakistanUnited KingdomCanada
In The Last Decade
Amna Ali
33 papers receiving 268 citations
Peers
Comparison fields: 5 of 93
- Pharmaceutical Science 52
- Health Informatics 7
- Biomaterials 53
- Molecular Medicine 8
- Infectious Diseases 28
Countries citing papers authored by Amna Ali
This map shows the geographic impact of Amna Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amna Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amna Ali more than expected).
Fields of papers citing papers by Amna Ali
This network shows the impact of papers produced by Amna Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amna Ali. The network helps show where Amna Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Amna Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 51 | |
| 2 | 2021 | 21 | |
| 3 | 2020 | 21 | |
| 4 | 2021 | 19 | |
| 5 | 2022 | 18 | |
| 6 | 2017 | 18 | |
| 7 | 2020 | 17 | |
| 8 | 2003 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2023 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 3 | |
| 20 | In vitro Antioxidant Activity, Phytochemical analysis and Cytotoxicity of Diospyros mespiliformis (leaves) | 2016 | 2 |
About Amna Ali
Amna Ali is a scholar working on Plant Science, Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science, having authored 38 papers that have together received 275 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Natural Antidiabetic Agents Studies (3 papers), Advanced Drug Delivery Systems (3 papers), Electrohydrodynamics and Fluid Dynamics (2 papers), Drug Solubulity and Delivery Systems (2 papers), Biochemical and Structural Characterization (2 papers) and Electrospun Nanofibers in Biomedical Applications (2 papers). The work is most often cited by research in Pharmaceutical Science (52 citations), Health Informatics (7 citations), Biomaterials (53 citations), Molecular Medicine (8 citations) and Infectious Diseases (28 citations). Amna Ali has collaborated with scholars based in Pakistan, United Kingdom and Canada. Frequent co-authors include Zeeshan Ahmad, Ming‐Wei Chang, Muhammad Sohail Arshad, Elshaimaa Sayed, Omar Qutachi, Alsiddig Osama, Neenu Singh, J. Gordon Hall, Benjamin Fine and David D Evans. Their work appears in journals such as Journal of Drug Delivery Science and Technology, International Journal of Pharmaceutics, Scientific Reports, Canadian Journal of Diabetes and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.